By Topic

Issues in ethics: the biomaterials crisis

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)

Several major suppliers of material used in medical devices, including Dow Chemical, Dow Corning and DuPont have recently decided not to sell these materials to device manufacturers. Other material suppliers have done the same or are reviewing their policies on this matter. Some of the biomaterials that have been or may soon become unavailable for medical device manufacturing include polyurethane for heart valves, polyethelene for artificial joints and silicone for implants. The withdrawal of biomaterials suppliers is the result of a number of lawsuits filed against materials suppliers by persons claiming to have been injured by medical devices. The largest group consists of plaintiffs in breast implant litigation. The author considers contributing factors in law, the seriousness of the problem and solutions to the problem

Published in:

Engineering in Medicine and Biology Magazine, IEEE  (Volume:14 ,  Issue: 4 )